Literature DB >> 22480917

Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles.

Hanna Mannell1, Joachim Pircher, Franziska Fochler, Yvonn Stampnik, Thomas Räthel, Bernhard Gleich, Christian Plank, Olga Mykhaylyk, Chiheb Dahmani, Markus Wörnle, Andrea Ribeiro, Ulrich Pohl, Florian Krötz.   

Abstract

Site specific vascular gene delivery for therapeutic implications is favorable because of reduction of possible side effects. Yet this technology faces numerous hurdles that result in low transfection rates because of suboptimal delivery. Combining ultrasonic microbubble technology with magnetic nanoparticle enhanced gene transfer could make it possible to use the systemic vasculature as the route of application and to magnetically trap these compounds at the target of interest. In this study we show that magnetic nanoparticle-coated microbubbles bind plasmid DNA and successfully deliver it to endothelial cells in vitro and more importantly transport their cargo through the vascular system and specifically deliver it to the vascular wall in vivo at sites where microbubbles are retained by magnetic force and burst by local ultrasound application. This resulted in a significant enhancement in site specific gene delivery compared with the conventional microbubble technique. Thus, this technology may have promising therapeutic potential. FROM THE CLINICAL EDITOR: This work focuses on combining ultrasonic microbubble technology with magnetic nanoparticle enhanced gene transfer to enable targeted gene delivery via the systemic vasculature and magnetic trapping of these compounds at the target of interest.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480917     DOI: 10.1016/j.nano.2012.03.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  7 in total

1.  HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.

Authors:  Yvonn Heun; Kristin Pogoda; Martina Anton; Joachim Pircher; Alexander Pfeifer; Markus Woernle; Andrea Ribeiro; Petra Kameritsch; Olga Mykhaylyk; Christian Plank; Florian Kroetz; Ulrich Pohl; Hanna Mannell
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

Review 2.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

3.  Targeting of Magnetic Nanoparticle-coated Microbubbles to the Vascular Wall Empowers Site-specific Lentiviral Gene Delivery in vivo.

Authors:  Yvonn Heun; Staffan Hildebrand; Alexandra Heidsieck; Bernhard Gleich; Martina Anton; Joachim Pircher; Andrea Ribeiro; Olga Mykhaylyk; Dietmar Eberbeck; Daniela Wenzel; Alexander Pfeifer; Markus Woernle; Florian Krötz; Ulrich Pohl; Hanna Mannell
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

4.  Circulating Magnetic Microbubbles for Localized Real-Time Control of Drug Delivery by Ultrasonography-Guided Magnetic Targeting and Ultrasound.

Authors:  Beata Chertok; Robert Langer
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

5.  Enhanced effect of nuclear localization signal peptide during ultrasound‑targeted microbubble destruction‑mediated gene transfection.

Authors:  Sheng Cao; Qing Zhou; Jin-Ling Chen; Nan Jiang; Yi-Jia Wang; Qing Deng; Bo Hu; Rui-Qiang Guo
Journal:  Mol Med Rep       Date:  2017-05-31       Impact factor: 2.952

6.  A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery.

Authors:  Joshua Owen; Calum Crake; Jeong Yu Lee; Dario Carugo; Estelle Beguin; Alexandre A Khrapitchev; Richard J Browning; Nicola Sibson; Eleanor Stride
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

7.  The Phosphatase SHP-2 Activates HIF-1α in Wounds In Vivo by Inhibition of 26S Proteasome Activity.

Authors:  Yvonn Heun; Katharina Grundler Groterhorst; Kristin Pogoda; Bjoern F Kraemer; Alexander Pfeifer; Ulrich Pohl; Hanna Mannell
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.